Literature DB >> 12646238

Vasopressin-SV40 T antigen expression in transgenic mice induces brain tumor and lymphoma.

Jeong Woong Lee1, Jun Hong Park, Kil Soo Kim, Eun Ju Lee, Myoung Ok Kim, Sung Hyun Kim, Seong Whan Jeong, Chul Woo Kim, Ho Joon Lee, Kyung Sun Kang, Kyu Tae Chang, Byung Hwa Hyun, Zae Young Ryoo.   

Abstract

In order to understand the importance of various cis-acting elements in regulating VP gene expression, transgenic mice regulated by VP constructs were produced containing 3.8 kb of the 5' flanking region and all the exons and introns in the mouse VP gene, which was fused at the end of exon 3 to an SV40 T antigen (Tag). In the transgenic mice by the pVPSV.IGR3.6 construct, all the six transgenic mice died at the age of 2-6 weeks. In the transgenic mice by pVPSV.IGR2.1, 21% of them had brain tumors at 5 weeks and 100% of the mice had brain tumors after 24 weeks. Histological analysis of the transgenic mice revealed primitive neuroectodermal tumors (PNET) in the brain and lymphoma in the spleen and lymph nodes. The phenotype differences between the two transgenic mice suggest that tissue-specific expression might be regulated by cis-acting elements in the 1.5-kb of the 3(') flanking region, which are not contained in pVPSV.IGR2.1. In conclusion, pVPSV.IGR2.1 mice will be a valuable mouse model system for investigating PNET tumorigenesis in the brain and lymphoma in the lymph nodes and spleen.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12646238     DOI: 10.1016/s0006-291x(03)00225-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

Review 1.  Cell-type specific expression of oxytocin and vasopressin genes: an experimental odyssey.

Authors:  H Gainer
Journal:  J Neuroendocrinol       Date:  2012-04       Impact factor: 3.627

2.  Absence of simian virus 40 DNA sequences in primary central nervous system lymphoma in HIV-negative patients.

Authors:  Manuel Montesinos-Rongen; Razvan Besleaga; Susanne Heinsohn; Reiner Siebert; Hartmut Kabisch; Otmar D Wiestler; Martina Deckert
Journal:  Virchows Arch       Date:  2004-03-24       Impact factor: 4.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.